Charles Schwab Investment Management Inc. grew its stake in shares of ChampionX Co. (NASDAQ:CHX - Free Report) by 2.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,679,414 shares of the company's stock after acquiring an additional 56,283 shares during the period. Charles Schwab Investment Management Inc. owned 1.41% of ChampionX worth $72,853,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of CHX. Van ECK Associates Corp raised its position in shares of ChampionX by 0.3% in the fourth quarter. Van ECK Associates Corp now owns 2,639,352 shares of the company's stock valued at $71,764,000 after buying an additional 9,056 shares in the last quarter. Quest Partners LLC raised its position in shares of ChampionX by 86.8% in the third quarter. Quest Partners LLC now owns 69,102 shares of the company's stock valued at $2,083,000 after buying an additional 32,103 shares in the last quarter. Silphium Asset Management Ltd raised its position in shares of ChampionX by 88.1% in the fourth quarter. Silphium Asset Management Ltd now owns 366,132 shares of the company's stock valued at $9,955,000 after buying an additional 171,531 shares in the last quarter. State Street Corp raised its position in shares of ChampionX by 1.7% in the third quarter. State Street Corp now owns 7,422,097 shares of the company's stock valued at $223,776,000 after buying an additional 122,622 shares in the last quarter. Finally, Barclays PLC raised its position in shares of ChampionX by 147.2% in the third quarter. Barclays PLC now owns 357,081 shares of the company's stock valued at $10,766,000 after buying an additional 212,654 shares in the last quarter. 98.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Separately, Citigroup dropped their price target on shares of ChampionX from $45.00 to $40.00 and set a "buy" rating for the company in a research report on Thursday, November 14th.
Get Our Latest Stock Analysis on ChampionX
ChampionX Stock Performance
Shares of NASDAQ:CHX opened at $28.54 on Wednesday. The company's 50 day simple moving average is $29.05 and its 200 day simple moving average is $29.53. The stock has a market capitalization of $5.45 billion, a price-to-earnings ratio of 17.30 and a beta of 2.28. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.99 and a quick ratio of 1.36. ChampionX Co. has a 1 year low of $25.57 and a 1 year high of $39.95.
ChampionX (NASDAQ:CHX - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.03. ChampionX had a net margin of 8.81% and a return on equity of 19.84%. As a group, research analysts predict that ChampionX Co. will post 1.92 EPS for the current fiscal year.
ChampionX Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, April 4th will be paid a $0.095 dividend. The ex-dividend date of this dividend is Friday, April 4th. This represents a $0.38 dividend on an annualized basis and a yield of 1.33%. ChampionX's dividend payout ratio (DPR) is 23.03%.
About ChampionX
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
